Ginkgo Bioworks Holdings Inc Class (DNA)
Cash & Short-Term Investments
$302.16M
Quarterly · Period ending: · USD
DNA Cash & Short-Term Investments
Latest reported$302.16Mperiod ending
Latest reported$302.16Mperiod ending
DNA Quarterly Cash & Short-Term Investments ($495.29M → $302.16M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
DNA cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 302,163,000 | |
| 373,456,000 | |
| 422,620,000 | |
| 461,862,000 | |
| 473,691,000 | |
| 516,922,000 | |
| 561,572,000 | |
| 616,214,000 | |
| 730,367,000 | |
| 843,768,000 | |
| 944,073,000 | |
| 1,049,244,000 | |
| 1,105,787,000 | |
| 1,206,086,000 | |
| 1,315,792,000 | |
| 1,302,603,000 | |
| 1,377,152,000 | |
| 1,492,971,000 | |
| 1,550,004,000 | |
| 1,739,056,000 | |
| 235,893,000 | |
| 308,128,000 | |
| 380,801,000 | |
| 495,287,000 |